HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation.

AbstractBACKGROUND:
The purpose of this study was to report the long-term outcome of patients with squamous cell cancer (SCC) of the tonsil managed by surgery followed by postoperative radiotherapy (PORT).
METHODS:
Eighty-eight patients treated between 1985 and 2005 were analyzed. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) were determined by the Kaplan-Meier method. Factors predictive of outcome were determined by univariate and multivariate analysis.
RESULTS:
Forty-eight percent of patients had T3 to T4 disease and 75% had a positive neck. Five-year OS, DSS, and RFS were 66%, 82%, and 80%, respectively. The status of the neck was not predictive of outcome (DSS 80% for N0 vs 82% for N+; p = .97). Lymphovascular invasion was an independent predictor of OS, DSS, and RFS on multivariate analysis.
CONCLUSION:
Lymphovascular invasion but not pathological stage of the neck is an independent predictor of outcome in patients with tonsillar SCC.
AuthorsRahmatullah Rahmati, Snjezana Dogan, Owen Pyke, Frank Palmer, Mahmoud Awad, Nancy Lee, Dennis H Kraus, Jatin P Shah, Snehal G Patel, Ian Ganly
JournalHead & neck (Head Neck) Vol. 37 Issue 6 Pg. 800-7 (Jun 2015) ISSN: 1097-0347 [Electronic] United States
PMID24616252 (Publication Type: Journal Article)
Copyright© 2014 Wiley Periodicals, Inc.
Topics
  • Analysis of Variance
  • Carcinoma, Squamous Cell (mortality, pathology, radiotherapy, surgery)
  • Cohort Studies
  • Confidence Intervals
  • Disease-Free Survival
  • Female
  • Humans
  • Lymph Nodes (pathology, surgery)
  • Male
  • Multivariate Analysis
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Staging
  • Prognosis
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Risk Assessment
  • Survival Analysis
  • Tonsillar Neoplasms (mortality, pathology, radiotherapy, surgery)
  • Tonsillectomy (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: